Early administration of ubrogepant was associated with a significant improvement in migraine symptoms compared with placebo.

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

"We observed in this cohort study that BMI outside of the normal category in women and men was associated with lower ...

Vitamin D is linked to a 34% reduction in the relative risk for disease activity in patients with clinically isolated ...